The Scientific Advisory Team at Zynerba Pharma provides expert guidance on the research and development of novel cannabinoid therapeutics, ensuring they meet the highest scientific and clinical standards. Comprised of leading scientific advisors and coordinated by the Research Study Coordinator, this team evaluates clinical data, advises on study designs, regulatory strategies, and helps align the company's initiatives with the latest scientific advancements to address unmet medical needs in neuropsychiatric disorders.
Carrie Buchanan
Scientific Advisor
Craig A. Erikson
Scientific Advisor
Elizabeth M. Berry-K...
Scientific Advisor
Helen Heussler
Scientific Advisor
Kathleen Angkustsiri
Scientific Advisor
Melanie van Buuren
Research Study Coordinator
Nicole Tartaglia
Scientific Advisor
Randi J. Hagerman
Scientific Advisor
Steven J. Siegel
Scientific Advisor
Tony Simon
Scientific Advisor
View all